5129-22-6

Basic information

• Product Name: 3-amino-4-ethylbenzenemethanol
• Synonyms: 3-amino-4-ethylbenzenemethanol
• CAS NO: 5129-22-6
• Molecular Weight: 151.208
• Mol File: 5129-22-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-amino-4-ethylbenzenemethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-amino-4-ethylbenzenemethanol(5129-22-6)
• EPA Substance Registry System: 3-amino-4-ethylbenzenemethanol(5129-22-6)

Safety Data

• Hazardous Substances Data: 5129-22-6(Hazardous Substances Data)

Upstream product

• 1449515-89-2 (4-ethyl-3-nitrophenyl)methanol 
• 4748-80-5 4-ethyl-3-nitro-benzaldehyde 

Downstream Products

• 1449514-94-6 (4-ethyl-3-(1-methyl-1H-imidazo[4,5-c]pyridin-6-ylamino)phenyl)methanol 
• 1449664-64-5 (4-ehyl-3-(methyl(1-methyl-1H-midazo[4,5-c]pyridin-6-yl)amino)phenyl)methanol 
• 1449664-68-9 N-(2-ethyl-5-(methoxymethyl)phenyl)-N,1-dimethyl-1H-imidazo[4,5-c]pyridin-6-amine 
• 100-21-0 terephthalic acid 

Relevant articles and documents

IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, wherein R1 and Cy are as disclosed herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.